News Item Archive
[First/Prev] 1, 2, 3, 4, 5, 6, 7 [Next/Last]| Posted Date | Description |
|---|---|
| 07/07/2010 | Fluoropyrimidine Pathways in Pharmacogenetics and Genomics |
| 07/07/2010 | CYP2B6 VIP in Pharmacogenetics and Genomics |
| 06/23/2010 | Very Important Pharmacogene Information for PTGS2(COX2) |
| 06/23/2010 | Very Important Pharmacogene Information for NR1I2(PXR) |
| 05/10/2010 | Clopidogrel Pathway in Pharmacogenetics and Genomics |
| 05/10/2010 | Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9. |
| 04/30/2010 | Clinical assessment incorporating a personal genome |
| 04/30/2010 | Challenges in the clinical application of whole-genome sequencing |
| 04/26/2010 | The utility of general purpose versus specialty clinical databases for research: Warfarin dose estimation from extracted clinical variables. |
| 04/26/2010 | Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism. |
PharmGKB® is a registered trademark of HHS and is
financially supported by NIH/NIGMS.
It is managed at Stanford University (GM61374).
©2001-2010 PharmGKB.
©2001-2010 PharmGKB.